Esketamine is approved in Europe for treating resistant major depressive disorder
Year: 2019
Type: other
Source: BMJ
DOI: 10.1136/bmj.l7069
Author: Elisabeth Mahase
Institution: BMJ Group (United Kingdom)
Language: English
Subfield: Pharmacology (medical)
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W2996380708
